Pr Stéphane Oudard
- Spécialité
- Oncologue médical, expert urologie
- Titre
- Chef de service
- Hôpital
- Hôpital Européen Georges Pompidou (Paris)
- Derniers articles
-
- Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma. (8 mai 2025)
- Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT). (2 mai 2025)
- Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study. (1 mai 2025)
- Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients. (1 avr. 2025)
- Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma. (14 févr. 2025)